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The development of short-read, next-generation sequencing (NGS) has revolutionized 
biological research, agriculture and medicine, enabling innovations such as genomic selection to 
raise crop yields and precision medicine to diagnose and treat disease. The genetic 
polymorphisms identified by this high-throughput sequencing can serve as markers for 
association with phenotypic traits. Variant calling refers to the process of detecting genetic 
polymorphisms based on analysis of genome sequence data output by NGS technology. The 
projects described here investigate these analysis methods. 
Chapter One reviews variant calling and its application to human and plant genomic data. 
It opens by detailing the generation of sequence reads from biological samples and the 
conversion of those reads to meaningful data, emphasizing the importance of tool selection for 
analysis. Next, the use of sequencing to identify genetic risk factors in the context of Alzheimer’s 
disease is reviewed. The chapter concludes by describing the application of sequencing to 
analysis of plant genomes. 
Chapter Two presents a study of the impact of batch effect and study design on 
identification of genetic risk factors in human sequencing data. Sequencing-based searches for 
disease-associated variants require large sample sizes to achieve sufficient statistical power, but 
they often entail batch effects and biases from study design, both of which hinder the ability to 
detect true genotype-trait associations. We studied batch effects and confounding variables in 
whole-exome data from the Alzheimer’s Disease Sequencing Project and demonstrated that 
both significantly impacted the association analysis. In particular, we identified variants with 
novel disease associations that may have been influenced by population stratification and a 
confounding effect of age. 
Chapter Three reports a comparison of genotyping-by-sequencing (GBS) analysis 
methods on plant data. As a reduced-representation sequencing method to identify genetic 
variants and quickly genotype samples, GBS produces extensive missing data and requires 
complex bioinformatics analysis, particularly in the context of plants, which have highly variable 
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ploidy and repeat content. To address issues identified with existing methods, we developed 
GB-eaSy, a GBS bioinformatics pipeline that incorporates widely used genomics tools, 
parallelization and automation to increase the accuracy and accessibility of GBS data analysis. A 
comparison of five GBS pipelines using low-coverage sequence data from soybean 
demonstrated that GB-eaSy rapidly and accurately identified the greatest number of variants. In 
addition, the unexpectedly low convergence between the five analysis methods but generally 
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CHAPTER 1: GENOMIC VARIANT CALLING WITH APPLICATION TO HUMAN AND PLANT DATA 
 
OVERVIEW OF GENOMIC VARIANT CALLING 
The development of short-read, next-generation sequencing (NGS) has revolutionized 
biological research, agriculture and medicine, enabling innovations such as genomic selection to 
raise crop yields and precision medicine to diagnose and treat disease. The genetic 
polymorphisms identified by this high-throughput sequencing can serve as markers for 
association with phenotypic traits. Variant calling refers to the process of detecting genetic 
polymorphisms based on analysis of sequence reads output by NGS technology.  
NGS technology relies on sequencing by synthesis, in which short segments of cut DNA 
serve as templates for generation of complementary sequences composed of fluorescently 
tagged nucleotide bases (Nielsen et al. 2011). During synthesis of these complementary 
sequences by DNA polymerase, the addition of each tagged nucleotide is recorded by a camera. 
The sequencer outputs strings of nucleotide bases, or “reads,” corresponding to these 
sequences, and each nucleotide base is assigned a quality score that measures the confidence 
of the base call. This high-throughput procedure occurs simultaneously for tens of millions of 
DNA templates in a single sequencing machine.  
In order to determine the genomic origin of the sequence reads output by the sequencer, 
they must be assembled into larger contigs, often with the aid of a previously assembled and 
annotated reference genome. Alignment refers to the computational process of mapping 
sequence reads against a reference genome. Widely used alignment software tools include BWA 
(H. Li and Durbin 2009; H. Li 2013), Novoalign (www.novocraft.com) and Bowtie2 (Langmead et 
al. 2009). Although these utilities perform the same basic function, each relies on a unique set 
of algorithms and procedures, often resulting in somewhat different outcomes or performance. 
For example, BWA use the Burrows-Wheeler transform algorithm, while Novoalign uses the 
Needleman-Wunsch algorithm (H. Li and Durbin 2009; Thankaswamy-Kosalai et al. 2017). 
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Studies comparing multiple aligners have shown that Novoalign achieves the greatest accuracy, 
but BWA is almost as accurate, considerably faster and less computationally costly (H. Li 2013; 
Thankaswamy-Kosalai et al. 2017).  
A standard step after alignment is recalibration of base quality scores to correct 
systematic bias in base-quality computation by the sequencer. Perhaps the most widely used 
tool for recalibration is the Base Quality Score Recalibration (BQSR) algorithm implemented in 
the Genome Analysis Toolkit (GATK) software (Van der Auwera et al. 2013). BQSR creates a 
model of covariation for base quality scores (e.g. based on machine cycle, original quality score, 
dinucleotide content, location of nucleotide in the read, etc.) and adjusts quality scores to 
account for this variation. 
Mapped reads with recomputed quality scores serve as input for variant calling, the 
identification of sampled sites polymorphic to the reference genome sequence. Most current 
variant calling tools, such as GATK HaplotypeCaller (Van der Auwera et al. 2013) and SAMtools 
(H. Li et al. 2009), use Bayesian statistical analysis of the base calls and quality scores to identify 
variant sites (Nielsen et al. 2011; O’Rawe et al. 2013). After variant calling, the process of 
genotype calling, which some tools combine with variant calling in one step, involves 
determining the consensus genotype in a group of reads from a particular sample and whether 
that consensus varies from the reference. Software programs for variant calling function on a 
per-sample basis, but genotype calling may be conducted either on a per-sample or joint basis. 
Joint genotyping achieves higher accuracy by leveraging information from all sequenced 
individuals to determine the genotypes at the variant positions identified 
(https://gatkforums.broadinstitute.org/gatk/discussion/4150/should-i-analyze-my-samples-
alone-or-together); this method can rescue less-confident genotype calls that would otherwise 
be discarded. After variant calling and genotyping, filtering steps are implemented to minimize 
the number of false positive variants in the dataset. Downstream applications for the filtered 
variants include genome-wide association studies (GWAS) – which statistically analyze the 
variants to find genetic loci correlated with a trait of interest – population genetics studies, and 
measurement of RNA expression levels. 
The choice of bioinformatics tools to process genomic data greatly influences the final 
set of detected variants. Different alignment and variant calling software packages rely on 
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different statistical models and computational algorithms, resulting in a substantial portion of 
non-overlapping variants between workflows implemented on the same raw data (O’Rawe et al. 
2013; Pirooznia et al. 2014; Wickland et al. 2017), especially for low-frequency variants and 
large cohort sizes (Ren et al. 2018). Despite the lack of consensus among workflows, 
comparison of the variant call sets to highly confident, “gold standard” reference variant calls 
indicates that most of the variants uniquely identified by individual methods are valid. These 
results suggest that the optimal strategy to capture as many true variants as possible is to 
combine multiple analytic approaches (O’Rawe et al. 2013; Ren et al. 2018; Wickland et al. 
2017). This integration strategy is especially critical in the search for the low-frequency (1-5%) 
and rare (frequency <1% ) variants because each method on its own delivers an incomplete call 
set.  
 
ALZHEIMER’S DISEASE GENOMICS 
 
OVERVIEW OF ALZHEIMER’S DISEASE  
Alzheimer’s disease (AD) is a progressive neurological disorder characterized by 
dementia, pathological protein aggregation, synaptic degradation, and neural atrophy. In the 
U.S. alone, it affects over 5 million people and its medical costs amount to $250 billion annually, 
figures projected to increase to 14 million people and $1 trillion by 2050 (Hebert et al. 2013; 
Alzheimer’s Association 2018). An estimated 3% of people aged 65-74, 17% of people aged 75-
84, and 32% of people aged 85 and older have AD (Hebert et al. 2013). As the most common 
cause of dementia, AD impairs virtually all aspects of cognition, especially memory. Clinical 
symptoms typically surface after age 65, but the underlying neuropathological lesions can begin 
to emerge years or even decades earlier (Sperling et al. 2011). Although symptoms may first 
appear as occasional forgetfulness or mild short-term memory impairment, over time they 
eventually progress to the severe cognitive deficits characteristic of dementia, in which 
deteriorated brain function interferes with the most basic tasks of living (Sperling et al. 2011; 
Alzheimer’s Association 2018).  
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Clinical diagnosis of possible AD, probable AD and dementia relies on cognitive and 
behavioral evaluation, often supplemented by assessment of chemical or neuroimaging 
biomarkers (Hyman et al. 2013; Frisoni et al. 2017). However, only histological inspection of 
brain tissue at autopsy can conclusively reveal the cell loss and key neural pathologies required 
for definitive AD diagnosis: extracellular amyloid plaques and intracellular neurofibrillary tangles. 
Amyloid plaques consist of aggregated amyloid beta, while neurofibrillary tangles consist of 
aggregated tau protein. Amyloid beta, tau and their precursor proteins play important roles in 
neural structure and function, but abnormal protein processing and age-related degeneration of 
protein homeostasis networks compromise the brain’s ability to counteract perturbations in 
these pathways (Pearson and Peers 2006; Jack et al. 2010; Penke et al. 2017). 
Amyloid beta forms from cleavage of Amyloid Precursor Protein (APP), a transmembrane 
protein that functions in synaptic formation and maintenance, signal transduction, and neural 
homeostasis and survival (Penke et al. 2017). APP cleavage occurs through two pathways; ninety 
percent of APP undergoes processing by the primary pathway, which yields products with 
neuroprotective and damage repair functions, while the remaining 10% of APP reaches the 
secondary pathway that generates amyloid beta. The normal functions of amyloid beta, present 
only at low concentrations, include roles in lipid transport, neuronal excitability and 
homeostasis, and synaptic plasticity (Pearson and Peers 2006; C. Liu et al. 2013). However, 
amyloid beta at high concentrations aggregates into plaques that contribute to AD pathogenesis. 
These high concentrations of amyloid beta disrupt synaptic signaling, degrade neural structure, 
and impair neural metabolism. Amyloid beta toxicity depends in part on tau, the other protein 
implicated in AD neuropathology (Penke et al. 2017).  
Tau is a microtubule-associated protein involved in assembly and stabilization of 
microtubules in neurons (Guo et al. 2017). Phosphorylation of tau protein controls its activity. 
Normal, non-pathogenic phosphorylation of tau occurs transiently at low levels and functions in 
neuroprotection (Iqbal et al. 2010). In AD, however, levels of tau hyperphosphorylation exceed 
those of normal neurons by 3-4x. This irreversible hyperphosphorylation triggers apoptosis and 
promotes the accumulation of tau into neurofibrillary tangles that destabilize microtubules, 
interfere with cell signaling, and disrupt cognitive function (Iqbal et al. 2010; Guo et al. 2017). 
These tangles, which are not readily degraded, spread throughout the brain in a predictable 
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progression (Braak and Braak 1991; Hyman et al. 2013); reminiscent of prions, they appear to 
propagate intercellularly to induce formation of additional aberrant tau conformations (Guo et 
al. 2017). 
The formation of neurofibrillary tangles and amyloid plaques typically precedes clinical 
manifestation of AD, and the extent of these accumulations generally correlates with dementia 
severity (Braak and Braak 1991; Sperling et al. 2011; Hyman et al. 2013). However, substantial 
patient-to-patent variability complicates efforts to understand the relationship between these 
neuropathological changes and cognitive impairment. The appearance of Alzheimer’s lesions 
may not coincide with clinical symptoms of dementia, particularly in the early stages of the 
disease; some individuals even remain cognitively normal until death despite postmortem 
detection of widespread AD lesions (Sperling et al. 2011; Hyman et al. 2013). Interestingly, 
certain lifestyle factors, such as advanced educational attainment and regular intellectual 
activity, may help build “cognitive reserve”; this compensatory mechanism buffers against 
intellectual impairment by recruiting alternate cognitive resources or coping strategies (Sperling 
et al. 2011; C. Liu et al. 2013). These findings and others suggest that deposits of amyloid beta 
and tau are necessary but not sufficient to cause AD symptoms. Finally, the AD lesions 
themselves also exhibit diversity in assembly state, length, and post-translational modifications 
(Hyman et al. 2013). These variabilities have impeded efforts to characterize the genetic basis of 
AD. 
 
ALZHEIMER’S DISEASE GENOMICS AND MISSING HERITABILITY 
Alzheimer’s disease has a strong genetic component, with heritability estimated at 60-80% 
(Gatz et al. 2006; Ertekin-Taner 2007). Heritability, or the proportion of a trait’s phenotypic 
variance determined by additive genetic factors, is estimated based on phenotypic correlation 
data from closely related individuals (e.g. twin studies) (Yang et al. 2017). The genetics 
underlying AD heritability differ between the two broad classes of AD: early-onset AD (EOAD) 
and late-onset AD (LOAD). EOAD, which comprises 1% of AD cases, emerges before age 65, 
while late-onset AD (LOAD), which comprises all other cases, emerges after age 65 (C. Liu et al. 
2013). Key factors contributing to EOAD heritability are highly penetrant, pathogenic mutations 
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in Presenilin1 (PSEN1), Presenilin2 (PSEN2) and the APP gene, all of which encode proteins that 
influence amyloid beta processing (Ertekin-Taner 2007; C. Liu et al. 2013; Cuyvers and Sleegers 
2016). 
The genetics of LOAD are more complex. The most well-established AD risk gene, APOE, 
encodes Apolipoprotein, which functions in cholesterol transport and neural response to injury 
(C. Liu et al. 2013). Two non-synonymous single nucleotide polymorphisms (SNPs) –  Rs429358 
(https://www.snpedia.com/index.php/Rs429358) and Rs7412 
(https://www.snpedia.com/index.php/Rs7412) – in APOE create three haplotypes at this locus, 
referred to as the alleles APOE Ɛ2, APOE Ɛ3 and APOE Ɛ4. These alleles generate three isoforms 
of the APOE protein – APOE2 (Cys112, Cys158), APOE3 (Cys112, Arg158) and APOE4 (Arg112, 
Arg158) – each with a different contribution to AD susceptibility (Richard et al. 1994). 
Accounting for 17-27% of AD heritability, the Ɛ4 allele of APOE is the single greatest genetic risk 
factor for LOAD  (Lambert 2013; Ridge et al. 2013; Cuyvers and Sleegers 2016). The Ɛ4/Ɛ4 
genotype greatly increases an individual’s risk of developing AD; 40% of AD patients, but just 15% 
of the general population, carry this genotype (Rubinsztein and Easton 1999). Compared to the 
most common genotype (Ɛ3/Ɛ3), Ɛ4 in one copy raises AD risk by ~3x and in two copies by ~15x 
among Caucasians, with a fairly similar pattern in other ethnic groups (Farrer et al. 1997). At the 
neural level, both human and rat neurons expressing the Ɛ4 allele show elevated levels of 
amyloid beta and induction of tau phosphorylation (Shi et al. 2017; Wang et al. 2018). In 
contrast, the Ɛ2 allele exerts a neuroprotective effect, and in AD patients it apparently delays 
disease onset and attenuates amyloid beta deposition relative to Ɛ4 (Serrano-Pozo et al. 2015).  
GWAS have been undertaken to identify additional genetic factors associated with AD 
risk. Besides APOE, over 20 other AD-associated genes have been detected by GWAS (Cuyvers 
and Sleegers 2016). Functionally consequential variants lying within the coding sequence or 
regulatory regions of these genes have been reported, among them the AD risk alleles in Cluster 
(CLU), complement component receptor 1 (CRI), BIN1, CD33 and Sortilin-related receptor 1 
(SORL1). Despite these advances, these studies account for only a small fraction of the AD 
heritability deduced from phenotypic data (Ridge et al. 2013; Cuyvers and Sleegers 2016). The 
AD-associated loci thus far identified by GWAS, together with APOE Ɛ4, collectively explain 28-
57% of the disease’s heritability (Cuyvers and Sleegers 2016). The remaining heritability is 
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considered “missing.” The limitation of GWAS in accounting for trait heritability represents a 
major obstacle towards genetic characterization of this complex disease. The prevailing 
consensus is that LOAD results from a combination of common variants and rare, large-effect 
variants, the latter of which may comprise a substantial portion of the missing heritability 
(Cuyvers and Sleegers 2016; Lord et al. 2014; Marouli et al. 2017; Patel et al. 2019; Ridge et al. 
2013).  
Current research has focused on the contribution of rare mutations to AD risk. The case 
of the GWAS-detected gene SORL1 illustrates the relevance of rare mutations to AD. The SORL1 
protein modulates amyloid beta expression by preventing cleavage of APP into amyloid beta 
and by channeling newly synthesized amyloid beta to the lysosome for breakdown (Andersen et 
al. 2016). Recent reports have discovered very rare variants in this gene associated with 
substantially elevated AD risk. One study found rare, damaging SORL1 variants (minor allele 
frequency [MAF] < 1%) in some individuals with EOAD that increase AD risk by 5x (Nicolas et al. 
2016). Another report profiled additional highly penetrant, very rare SORL1 variants that confer 
even greater AD risk. In a whole-exome cohort of 640 cases and 1268 controls, the majority of 
the very rare (MAF < .01%) SORL1 variants predicted (by functional annotation tools) to be 
strongly damaging appeared only in single individuals (Holstege et al. 2017). Individuals carrying 
these strongly damaging “singletons” were over 10x more likely to develop AD, and the five 
singletons resulting in protein frameshift or truncation were observed only in AD cases. In 
addition, AD cases carrying these singletons had an earlier age of onset (58.9) than cases lacking 
these singletons (65.1). Conversely, more common variants identified in this study showed no 
association with AD risk, even when predicted to be strongly damaging based on protein 
changes.  
To identify rare alleles, a current trend in AD sequencing studies is the use of large 
cohorts, which are required not only to capture the low-frequency variants themselves but also 
to achieve sufficient statistical power to establish the variants’ significant association with 
disease. In the context of GWAS, statistical power refers to the probability of recognizing a true 
association between disease and a genetic variant (i.e., correctly rejecting the null hypothesis of 
no association) (Sham and Purcell 2014). The Alzheimer’s Disease Sequencing Project (ADSP) 
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was initiated to identify novel AD-related genetic variation, and the large size of its case-control, 
whole-exome dataset of more than 10,000 samples was intended to raise statistical power 
compared to previous studies (Beecham et al. 2017). Recent reports have identified novel AD 
risk variants in this dataset and have offered additional support for previously established loci. 
One study found 11 variants – 8 of them residing in the APOE region of chromosome 19 – with 
statistically significant association with AD, as well as 14 suggestively significant variants (Bis et 
al. 2018). Of these significant SNPs, three falling outside of the APOE region reached significance 
in replication cohorts. However, no significant SNPs lying in genes with novel AD association 
reached significance in replication cohorts. Another study used a non-statistical approach to 
analyze this dataset (Patel et al. 2019). Rather than conducting conventional statistical tests, the 
researchers simply identified SNPs with MAF < 0.1%; discarded those with low predicted impact 
on disease, allele count below 3, or no effect on amino acid sequence; and counted the number 
of case or control individuals carrying these SNPs. This approach identified 32 SNPs in 24 
previously reported AD genes, including two SNPs (in TREM2 and NOTCH3) that were fully 
penetrant in the individuals carrying them.  
ADSP and other large-scale sequencing projects have sought to address the missing 
heritability issue by capitalizing on large-cohort datasets to capture variants that are rare. 
Despite some success for rare variants analysis, much of the genetic contribution to AD remains 
unknown. Given the complexity of AD genetics and variability in AD phenotype, disease onset 
and disease progression, it is plausible that important types of genetic variation have not been 
explored sufficiently. Synonymous SNPs represent one such form of variation. 
 
SYNONYMOUS SNPS AND THEIR POTENTIAL ROLE IN AD 
The degeneracy of the genetic code allows multiple codons to specify a given amino acid. 
Synonymous SNPs are nucleotide substitutions that encode the same codon as the reference, 
“wild-type” sequence. Association studies typically disregard these variants because they do not 
alter a protein’s amino acid composition. However, the unequal frequencies of synonymous 
codons throughout the genome, known as codon usage bias, suggests their susceptibility to 
forces of selection and their functional significance (Chamary et al. 2006; Drummond and Wilke 
2008). Indeed, synonymous SNPs can impact mRNA stability, translation speed and protein 
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structure and function (Chamary et al. 2006; Spencer et al. 2012; Sauna and Kimchi-Sarfaty 
2011). The two classes of mutations typically studied, non-synonymous and frameshift 
mutations, represent the largest proportion of rare alleles, which are presumably deleterious 
and subject to purifying selection (Im et al. 2018). Synonymous SNPs comprise the second most 
abundant class of rare alleles, outnumbering the rare alleles of both introns and untranslated 
regions; this further suggests that these so-called “silent” mutations are under selection.  
Because of their slightly different nucleotide compositions, synonymous codons can 
introduce subtle changes to mRNA secondary structure that influence the molecule’s stability, 
which in turn affects its rate of degradation and ability to initiate translation (Gu et al. 2010; 
Sauna and Kimchi-Sarfaty 2011). For instance, more stable mRNA is less readily degraded and 
less readily translated. In addition, codon usage bias is linked to the composition of the tRNA 
pool in many organisms, including humans; more abundant codons, particularly in highly 
expressed genes, generally correspond to more concentrated isoacceptor tRNA species that 
recognize those codons, which maximizes the speed and accuracy of translation (Ikemura 1985; 
Lavner and Kotlar 2005; Chamary et al. 2006; Drummond and Wilke 2008; Yu et al. 2015). By 
affecting the rate of translational elongation, codon usage also modulates co-translational 
protein folding, a process that influences protein function (Spencer et al. 2012; Yu et al. 2015). 
For example, in many highly expressed proteins, structurally important amino acid residues are 
encoded by translationally optimal codons, a relationship that reduces the likelihood of protein 
misfolding arising from ribosomal stalling (Zhou et al. 2009). 
Synonymous SNPs have been discovered in genes that underlie human diseases ranging 
from breast cancer to Crohn’s disease (Hunt et al. 2014). A synonymous SNP in the 
Tristetraprolin (TTP) gene, which functions in suppression of breast cancer tumorigenesis, 
reduces expression of TTP protein by hampering translational efficiency (Griseri et al. 2011). 
Similarly, two synonymous SNPs in high-temperature requirement A1 (HTRA1), a gene strongly 
linked to neovascular age-related macular degeneration, are over-represented in individuals 
afflicted with this condition. These synonymous SNPs, each involving a switch to a less 
frequently used codon, result in similar mRNA expression but reduced protein production and 
reduced catalytic activity relative to wild-type codons, apparently by slowing translation speed 
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and interfering with protein folding (Jacobo et al. 2013). Finally, a synonymous SNP in the cystic 
fibrosis transmembrane conductance regulator (CFTR), which coordinates the movement of ions 
across epithelial cell membranes, has been documented in individuals with cystic fibrosis 
(Kirchner et al. 2017). While still specifying the amino acid threonine, this T-to-G SNP has a low-
abundance cognate tRNA in bronchial epithelial tissue. The low concentration of this tRNA 
retards translation, which alters co-translational folding and ultimately impairs ion channel 
conductance. These results establish that synonymous mutations can impact protein structure 
and function in disease-related genes.  
In the scientific literature, coverage of synonymous SNPs with respect to Alzheimer’s 
disease is sparse. One recent study found two genes containing synonymous SNPs correlated 
with entorhinal cortical thickness (an AD imaging biomarker) in individuals with AD (J. E. Miller 
et al. 2018). However, it is possible that these variants were simply markers in linkage 
disequilibrium with causative nucleotide changes or that the cortical thickness phenotype was 
not directly related to AD. Therefore, much remains unknown concerning the potential 
connection between synonymous variants and AD (see Chapter 2). 
 
 
GENOMIC SEQUENCING ANALYSIS IN PLANTS 
 
CHALLENGES IN PLANT GENOMICS 
Certain biological characteristics of plant genetics complicate the bioinformatic analysis 
of plant genomes relative to humans and other animals. Challenges associated with plant 
genomes include polyploidy and high repeat content (Jiao and Schneeberger 2017). Polyploids 
are organisms that possess more than two sets of homologous chromosomes. Widespread in 
plants compared to animals and other organisms (Orr 1990), polyploidy can originate from 
whole-genome duplication in a single species (autopolyploidy) or, more commonly, from 
chromosome doubling after interspecific hybridization (allopolyploidy) (Kyriakidou et al. 2018). 
An estimated 80% of flowering plants are polyploid or have a polyploid lineage. Many extant 
plants, such as soybean (Glycine max), are paleopolyploids whose duplication events occurred 
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millions of years ago and that have since undergone partial diploidization, the return to diploid-
like cytogenetic behavior as homeologs diverge (Blanc 2004; Schmutz et al. 2010; Walling et al. 
2006; Wolfe 2001; Kim et al. 2009). Polyploidy acts as a source of variation upon which 
evolution may act to introduce novel adaptations. For example, duplication of an ancestral 
flowering gene, likely from a whole-genome duplication event during angiosperm evolution (Y. 
Liu et al. 2016), led to diversification of function into separate clades with opposing roles in 
flowering initiation (reviewed in Wickland & Hanzawa, 2015). Polyploidy also buffers against the 
impact of deleterious mutations. Although useful biologically, the presence of closely related 
homeologous chromosomes presents challenges to mapping algorithms; during alignment, 
reads may be mapped to the wrong homeolog. In addition, failure to distinguish polymorphisms 
between sub-genomes (“homeoSNPs”) from true allelic SNPs further raises the error rate in the 
set of detected variants (Clevenger and Ozias-Akins 2015).  
A related characteristic of plant genomes that poses additional challenges is high repeat 
content, which is particularly common in plants (Nicholas et al. 2016). Repetitive sequences, 
especially long repeat sequences not fully spanned by short reads, impede correct read 
placement against the reference, raising the error rate (Claros et al. 2012; Treangen and 
Salzberg 2012). Leading contributors to high repeat content in plants are transposable elements, 
which are rich in repetitive sequences and comprise over half of the genomes of soybean and 
several grasses and over 85% of the maize genome  (Claros et al. 2012; Nicholas et al. 2016; 
Feschotte et al. 2002; Gao et al. 2012; Schmutz et al. 2010). High repetitiveness also influences 
assembly of the reference genome itself, and specialized assembly tools have been developed 
to handle the repetitiveness inherent in plant genomes (Bolger et al. 2017). In addition, several 
methods have been advanced that can help mitigate issues related to high repeat content in 
reference-based variant calling. For example, paired-end reads, which represent sequence from 
both ends of a DNA fragment, can facilitate correct read placement relative to the reference 
genome; each read in a pair may contain flanking sequence adjacent to a different side of the 
repetitive region. A related, and more recent, method is long-read sequencing technology, 
which produces reads over 10 kilobases in length (Jiao and Schneeberger 2017; Rhoads and Au 
2015). Advanced by companies such as Pacific Biosciences and Oxford Nanopore, this 
technology generates reads long enough to “sequence through” extensively repetitive regions; 
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however, per-nucleotide error rates remain relatively high compared to short-read sequencing 
and costs are usually much higher, making short-read sequencing the technology of choice for 
most variant detection applications.  
In addition to biological factors, financial considerations impact the analysis of plant 
genomes relative to those of humans. In 2019, the budget of the National Institutes of Health 
(NIH), the medical-research arm of the United States Department of Health and Human Services, 
exceeded $39 billion, more than 80% of which was distributed as competitive grants to 
researchers (https://www.nih.gov/about-nih/what-we-do/budget). In contrast, the United 
States Department of Agriculture (USDA) research budget in the same year amounted to $2.6 
billion; approximately half of this funded the research activities of the Agricultural Research 
Service (ARS) and the National Institute of Food and Agriculture (NIFA), the latter awarding $375 
million in competitive grants (United States Department of Agriculture, 2019). Although other 
sources of research funding exist, the large disparity in research budgets between the NIH and 
USDA reflects the reduced funding available for plant research compared to human/medical 
research at large. For this reason, many of the methods developed specifically for plant research 
aim to reduce costs wherever possible.  
 
GENOTYPING BY SEQUENCING (GBS) 
Whole-genome and whole-exome sequencing can identify millions of SNPs, but for many 
applications involving genetic linkage in plants, such high densities of markers are unnecessary 
and costly. Reduced-representation approaches involve sequencing a subset of locations spread 
throughout the genome to reduce genome complexity, minimize costs and rapidly genotype 
samples using SNP markers. The earliest developed reduced-representation sequencing method, 
restriction site associated DNA (RAD) sequencing, uses restriction enzymes to divide the 
genome into sheared DNA fragments, which are size fractionated and then sequenced on NGS 
platforms (Baird et al. 2008; M. R. Miller et al. 2007; Scheben et al. 2017). Often, restriction 
enzymes are selected that cut infrequently in repetitive regions in order to reduce the likelihood 
of obtaining reads that map to multiple locations. RAD sequencing remains the method of 
choice for biological diversity applications in which reference genomes are not available. In this 
and similar methods, each sample is assigned a unique barcoded adapter for multiplexed 
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sequencing in a single Illumina flow-cell lane, thereby increasing the number of samples under 
investigation and reducing financial costs. Although this method works well on crops such as 
soybean (Varala et al. 2011), the large amount of high-quality DNA required for the size 
selection step, and consequent higher DNA preparation costs, makes RAD sequencing 
unsuitable for routine use in plant breeding. 
Genotyping-by-sequencing (GBS), a simplified reduced-representation sequencing 
approach (Elshire et al. 2011), has gained popularity in crop research and plant breeding for 
high throughput, low-cost genotyping. It has been applied to projects ranging from genomic 
selection to gene mapping to GWAS in numerous crop species (Furuta et al. 2017; H. Liu et al. 
2014; Poland et al. 2012; Sonah et al. 2015; Wu et al. 2016). Like RAD sequencing, GBS relies on 
restriction enzymes to generate a reduced representation of the genome for sequencing. 
However, the GBS library preparation protocol involves fewer steps than RAD sequencing, 
requires less DNA, and lacks a size selection step (Elshire et al. 2011). In GBS, DNA samples are 
digested and ligated to barcoded adapters in single wells, pooled, and then enriched by PCR.  
Bioinformatics software packages and workflows have been developed to facilitate 
analysis of reduced-representation sequencing data (Catchen et al. 2013; Elshire et al. 2011; 
Sonah et al. 2013; Torkamaneh et al. 2017). Several of these platforms utilize the same tools and 
algorithms commonly applied to whole-genome sequence data, while others utilize algorithms 
developed specifically for GBS and RAD sequencing. Comparisons of GBS analysis methods show 
that a substantial portion of detected variants are unique to each bioinformatics tool (Sonah et 
al. 2013; Torkamaneh et al. 2016; Wickland et al. 2017). Contributions to this low overlap 
include the different statistical approaches used by each method to determine the consensus 
genotype in a group of reads and whether that consensus differs from the reference sequence. 
These methodological differences, combined with the polyploid nature of plant genomes and 
the large proportion of missing data inherent in GBS due to the reduced-representation 
approach, likely account for the lack of consensus between tools. Despite relatively low 
convergence between tools, SNP calls generally show high accuracy based on validation using 
other methods, indicating that different GBS analysis methods arrive at largely complementary 
sets of valid SNP calls. Therefore, a comprehensive approach integrating the results of multiple 
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bioinformatics pipelines may be a key strategy to obtain the largest, most highly accurate SNP 
yield possible for reduced-representation, low-coverage sequencing data (Wickland et al. 2017; 




























CHAPTER 2: THE IMPACT OF BATCH EFFECT AND STUDY DESIGN ON IDENTIFICATION OF 
GENETIC RISK FACTORS IN HUMAN SEQUENCING DATA 
 
BACKGROUND 
Genetic studies have shifted from SNP array-based genome-wide association study to 
rare variants discovery by exome and whole-genome sequencing. Sequencing-based searches 
for rare disease-associated variants require large sample sizes to achieve sufficient statistical 
power, but they often entail batch effects and biases from study design. Batch effects refer to 
sources of variation arising not from the targeted biological differences between phenotype 
classes but from differences between experimental or technological batches. If not adequately 
addressed in the analysis, batch effects reduce statistical power and raise susceptibility to false-
positive associations, and biases in study design may further hinder the ability to detect true 
genotype-trait associations. A standard practice in association studies is to use statistical models 
adjusted for batch effects and other heterogeneity in the dataset, followed by additional quality 
control of the identified genetic risk variants.  
Practices that may introduce batch effects include dividing samples among multiple 
sequencing centers, collecting samples under different protocols, and extracting exomes using 
different target capture kits. For example, the Alzheimer’s Disease Sequencing Project (ADSP) 
sequenced exomes of more than 10,000 cases and controls to identify genetic variations 
associated with Alzheimer’s disease (AD) (Beecham et al. 2017). Sequencing for this dataset 
took place at three centers: the Broad Institute (Broad), the McDonnell Genome Institute at 
Washington University (WashU), and the Human Genome Sequencing Center at Baylor College 
of Medicine (Baylor). Broad prepared sequencing libraries using the Illumina Rapid Capture 
Exome kit, while WashU and Baylor used the Roche Nimblegen VCRome v2.1 kit 
(https://www.niagads.org/adsp/content/sequencing-pipelines). In addition to three sequencing 
centers and two different exome capture kits, another potential confounding factor is the age 
distribution of sample classes, with cases averaging approximately 11 years younger than 
controls. The intentional selection of older controls was designed to identify AD-causal variants 
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that are absent from older but cognitively normal individuals, but this lack of independence 
between age and case-control status could also confound the association analyses.  
We studied batch effects and confounding variables in the ADSP dataset and found that 
both impacted the association analyses. In particular, we identified significant differences in 
genotype quality and allelic capture biases between the two exome capture kits. In addition, we 
investigated the influence of age and allele frequency differences between sequencing center 




The Sequence Read Archive (SRA) files containing the raw sequencing data of 10,993 AD 
cases and controls were downloaded from dbGap and converted to FASTQ format using the SRA 
Toolkit (https://www.ncbi.nlm.nih.gov/books/NBK158899). Access to this public dataset was 
approved by the Institutional Review Board (IRB) of Mayo Clinic, the IRB of the University of 
Illinois, and dbGAP (https://www.ncbi.nlm.nih.gov/gap/). The Alzheimer’s cases satisfied the 
National Institute on Aging and the Alzheimer’s Association criteria (McKhann et al. 2011) for 
definite, possible or probable Alzheimer’s disease. These cases included patients with and 
without APOE (Corder et al. 1993) risk alleles. The controls were at least 60 years old, showed 
no sign of dementia based on cognitive testing, and scored low on risk assessment (Beecham et 
al. 2017). Of the 10,993 samples, 9,904 passed sample-level quality control based on the 
following criteria: (1) variant call rate > 95% per sample; (2) coverage > 10x for at least 90% of 
exome; (3) APOE genotype match between cohort meta-data and sequenced genotypic data; (4) 
average transition/transversion ratio > 2.8; (5) FREEMIX (Jun et al. 2012) sample contamination 
estimate > 0.02 ; (6) gender error PLINK F estimate < 0.07 for males and > 0.03 for females. 
Ancestry of 99.8% of samples was classified as European.  
 
Variant calling 
The paired-end sequence reads were aligned to the human reference genome build 37 
using Novoalign (http://www.novocraft.com) (default parameters), which was selected on the 
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basis of its greater accuracy in read placement relative to other methods (H. Li 2013; 
Thankaswamy-Kosalai et al. 2017) and its lack of prior application to this dataset for association 
testing (e.g. Bis et al. 2018; Patel et al. 2019). The alignment files were then sorted by read 
position using Novosort (http://www.novocraft.com), realigned around small insertions and 
deletions (INDELs) using Picard (https://broadinstitute.github.io/picard/), and subjected to base 
recalibration using the Genome Analysis Toolkit (GATK) version 3.4 (Van der Auwera et al. 2013). 
Variant calling followed GATK’s best practices guidelines for germline variants 
(https://software.broadinstitute.org/gatk/best-practices/workflow?id=11145): per-sample 
variant calling on the realigned, recalibrated BAM files was performed using HaplotypeCaller, 
and multi-sample joint genotyping of all 9,904 samples was performed using GenotypeGVCFs. 
Variant calling was conducted only on the exome regions common between the two exome 
capture kits (Illumina Rapid Capture Exome kit and Nimblegen VCRome v2.1 kit). Variants were 
annotated by snpEff (Cingolani et al. 2012) and ANNOVAR (Wang et al. 2010). All data 
processing was carried out on the Blue Waters supercomputer at the University of Illinois at 
Urbana-Champaign. 
 
Variant-level quality control 
Several steps were undertaken to minimize the number of false-positive variant calls. 
The Variant Quality Score Recalibration (VQSR) step implemented in GATK uses machine 
learning algorithms to compute new, well-calibrated quality scores for all variants based on the 
annotations of a high-quality subset of the analyzed data. In accordance with GATK Best 
Practices for whole-exome data, the variables included in the VQSR model consisted of QD, MQ, 
MQRankSum, ReadPosRankSum, FS, SOR and InbreedingCoeff for SNPs; and QD, MQRankSum, 
ReadPOsRankSum, FS, SOR and InbreedingCoeff for INDELs (Van der Auwera et al. 2013). A 
sensitivity threshold of 99.5 was used for SNPs and 99.0 for INDELs. Detected variants were 
excluded from further analysis if they failed VQSR, deviated significantly (p < 1.0 x 10-6) from 
Hardy-Weinberg equilibrium (HWE) in the control samples, or had an alternate allele call 
supported by less than 10 reads across the cohort. 
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Association tests and statistical models 
After quality control, association testing using disease status (case or control) as the 
phenotype was performed on the variants under four additive logistic regression models 
implemented in Plink 1.9 (Chang et al. 2015). Each model included a unique combination of the 
following covariates: sequencing center, sex, age, APOE genotypes, and the first four principal 
components (PCs) underlying population structure (Table 2.1). All models adjusted for 
sequencing center and the first four PCs. Model 1 used only sequencing center and the first four 
PCs as covariates, leaving out APOE genotype and age because AD cases consisted of patients 
with and without APOE risk alleles and because age confounds with AD status. Model 2a 
included APOE genotypes as a covariate; Model 2b adjusted for age but left out APOE; and 
Model 3 adjusted for all listed covariates. The association tests were conducted on all 9,904 
samples together as well as on sets of samples stratified by sequencing center and age. Variants 
were considered exome-wide statistically significant at the Bonferroni-corrected threshold of p 
<  0.05 / # tests and suggestively significant at p < 1 / # tests (e.g. Bis et al. 2018).  
 
Principal components analysis 
Population substructure 
PCs of the detected genotypes were calculated after excluding variants that failed 
VQSR; variants with a call rate below 95%, minor allele frequency (MAF) below 5%, or 
HWE deviation below p < 1.0 x 10^-5; variants lying within the highly variable HLA, LCT, 
8p and 17q regions; and variants with a linkage disequilibrium r2 value above 0.2. Only 
the first four PCs had eigenvalues above 1, so these were retained in the statistical 
models for association testing to adjust for population substructure. 
 
Visualization of batch effect 
To explore the possibility that a batch effect originated from the use of two 
capture kits, we compared genotype-level quality metrics between the Broad cohort 
(Illumina kit) and the WashU and Baylor cohorts (Nimblegen kit). Quality metrics under 
consideration were genotype quality (GQ), read depth (DP) and minor allele 
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concentration (MAC). GQ measures the variant caller’s confidence in assigning a 
genotype at a given SNP for a given sample. DP refers to the number of sequenced reads 
that support a given genomic position for a given sample. MAC refers to the proportion 
of sequenced reads that support the minor allele, and is calculated by dividing the 
number of reads supporting the minor allele by the total number of reads at a given 
position for a given sample. 
Mean values for these three metrics at each variant position were computed 
separately for the Illumina-captured (Broad) samples and the Nimblegen-captured 
(WashU and Baylor) samples. The ratio of the means for each kit was taken at each SNP 
for each quality metric. Variants with large discrepancies between the two capture kits 
reside at the tails of the distribution of these ratios. To ascertain whether these 
discrepant variants could differentiate the genotypes detected by each capture kit, PCs 
were computed using as input the 9,904 samples’ genotypes at the SNPs lying within 1) 




Description of detected variants 
Of the 1,584,609 variants detected across the cohort, 166,947 variants passed VQSR and 
the additional filtering steps detailed above. These variants totaled 120,572 from the Broad 
samples; 108,390 from the WashU samples; and 98,542 from the Baylor samples. 
Approximately 70% of variants were shared among samples from all three sequencing centers 
(Figure 2.1). The larger number of variants detected in Broad samples is likely due to the larger 








 Full-cohort association analysis 
We first applied the four models (Table 2.1) to the full dataset of 9,904 samples. 
As shown in Figure 2.2, Models 2b and 3 identified very few significant variants, as 
expected, because age confounds with AD status. Under Model 1, which adjusted only 
for sequencing center and PCs, 73 variants reached exome-wide significance (p < 3.0 x 
10-7) and an additional 27 variants reached suggestive significance (p < 6.0 x 10^-6) 
(Figure 2.2). The most highly significant SNPs under this model reside on chromosome 
19, which contains well-established AD risk alleles and protective alleles in the gene 
APOE. Model 2a, which accounted for sequencing center and PCs as well as sex and 
APOE, found 43 significant variants and 48 additional suggestive variants (Figure 2.2). 
Most of these 43 SNPs and their corresponding genes had no previously reported 
association with AD (e.g. Bis et al. 2018). In addition, all significant variants detected 
under Model 2a were also significant under Model 1 (Figure 2.3). To characterize batch 
effects and other confounding variables, we focused on the 43 SNPs attaining exome-
wide significance under both Model 1 and 2a. These 43 SNPs were further filtered to 
remove multi-allelic SNPs, INDELs, and any SNP with a recalibrated variant quality score 
(VQSLOD) < 0, resulting in a set of 30 top SNPs for additional analysis (Table 2.3).  
 
The significance of AD association came from Broad samples only 
To investigate batch effects and other variables related to sequencing center, we 
repeated the four association models separately on the Broad, WashU and Baylor 
cohorts. Unexpectedly, at 28 of the 30 SNPs identified as exome-wide significant in the 
full-dataset analysis, only the Broad cohort remained significant (Figure 2.4). Two of the 
30 SNPs failed to reach significance in any individual cohort. Consistent with the 
observation of Broad-exclusive significance, the minor allele frequency (MAF) of the 28 
SNPs showed clear differences between cases and controls only in the Broad samples 
(Figure 2.5). These findings indicate that Broad cases drove the significance observed in 
the full cohort at these SNPs. This sequencing center difference was observed not only 
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at the top 30 SNPs; we examined all nominally significant AD variants (p < 0.005) and 
saw vast differences between sequencing centers (Figure 2.6). Under Model 1, only 8 
out of 1,730 nominally AD-associated (p < 0.005) variants were shared across all three 
centers; Models 2a, 2b, and 3 identified very few or zero AD variants shared across 
centers.  
 
Factors underlying the discrepancies between sequencing centers 
Genotype-level quality metrics by capture kit and sequencing center 
The surprisingly low overlap and incongruent significance of AD-associated 
variants across sequencing center cohorts prompted us to further examine the 
characteristics of the detected variants across these centers. Since Broad used a 
different exome capture kit than the one used by WashU and Baylor, we compared the 
genotype quality (GQ), read depth (DP) and minor allele concentration (MAC) at all 
detected SNPs (Figure 2.7). As shown in Figure 2.7a-b, the log-adjusted distributions of 
the GQ and DP ratios between the exomes captured by the Illumina kit (Broad) vs. 
Nimblegen kit (WashU and Bylor) are normal, with the tails corresponding to SNPs with 
bigger differences in GQ and DP between two capture kits. Interestingly, the top 10% (5% 
from each tail) of SNPs most discrepant in GQ, but not DP, between two exome kits 
contributed to the batch effects between sequencing centers; PCs computed based on 
these SNPs show clear separation by sequencing center for GQ (Figure 2.8). For MAC, 
Broad samples had substantially lower values consistent with biases of less efficient 
capture for the alternate allele by the Illumina exome capture kit, as indicated by the 
left-skewed distribution in Figure 2.7c and the PCs in Figure 2.8. In contrast, the middle 
90% of all three distributions showed no visual batch effect between sequencing centers 
(Figure 2.9). These results may indicate that global differences in GQ and MAC related to 
capture kit contributed to batch effects in this dataset.  
To assess the possibility that the disparate allele frequencies among sequencing 
center cohorts arose from sample-level quality issues, we next profiled for each center 
the distributions of GQ, DP and MAC of the 30 SNPs significant from the full-dataset 
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analysis. Possible GQ values range from 0 to 100, with 30 and above generally 
considered highly confident. Based on this metric, the 30 SNPs exhibited high quality in 
both cases and controls in the Broad, WashU and Baylor cohorts (with the possible 
exception of 19:42799299 in the gene CIC) (Figure 2.10). No consistent trends in GQ 
emerged between cases and controls or between samples from different centers. 
Although the distributions of DP varied widely among SNPs, for a given SNP they were 
generally similar across sequencing centers (Figure 2.11). MAC is expected to be near 50% 
because (in theory) approximately 50% of reads should support the alternate allele in a 
heterozygous individual. However, in practice MAC often has a lower value due to 
different sequencing affinities of the alleles. Similar to those of GQ and DP, the 
distributions of MAC showed no clear pattern of differences among sequencing centers 
(Figure 2.12). Therefore, sample quality at these 30 SNPs appeared relatively uniform 
across the full cohort. In addition, all but 4 of the 30 SNPs fell in the middle 90% of each 
global annotation ratio distribution described earlier, suggesting that quality issues did 
not fully explain the sequencing center differences manifested in the discrepant minor 
allele frequencies of the 30 SNPs profiled and that other unknown factors also 
contributed to batch effect in this dataset. 
 
Age distributions of cases and controls in Broad samples 
Next, we examined the reasons why exclusively the Broad-sequenced samples 
yielded 30 highly significant AD SNPs under Models 1 and 2a. As shown in Table 2.2 and 
Figure 2.13, Broad sequenced the largest ADSP cohort, including 48.7% of all cases and 
39.6% of all controls, indicating greater statistical power. In addition, Broad cases and 
controls had the biggest difference in average age, 13 years, compared to 8.5 and 10.5 
years for WashU and Baylor, respectively. Furthermore, the distribution of Broad cases is 
shifted towards younger individuals compared to the other two centers; we divided the 
samples into four age groups (<64, 65-74, 75-84 and 85+) and observed that Broad-
sequenced cases were over-represented in the younger age groups compared to WashU 






Association analysis stratified by sequencing center and age 
To examine the contribution of Broad’s over-representation of younger cases to center-
specific AD associations, we conducted the association tests separately on each of the four age 
groups listed above. Under this stratification scheme,  the AD association fell to levels below 
suggestive significance in all age groups except age 85+ (Figure 2.15). In Broad samples aged 85 
and older, 4 of the 30 SNPs attained exome-wide significance and an additional 4 SNPs attained 
suggestive significance. However, samples sequenced by WashU and Baylor failed to approach 
significance at any SNP. Intriguingly, the exome-wide significance in the oldest group at some of 
these SNPs in Broad may be due to a reverse of the MAF in cases vs. controls between 
individuals below or above age 74 (Figure 2.16). In Broad samples 74 years of age and younger, 
the MAF of nearly all of the top 30 SNPS was higher in controls compared to cases. However, in 
Broad samples older than 74 years, the MAF of nearly all top 30 SNPs was higher in cases 
compared to controls, which may have contributed to the significant p-values of these risk 
variants. In addition, both cases and controls sequenced by Broad showed declining MAF with 
age, suggesting that the SNPs are associated with age in these samples. These observations may 
indicate that the AD association detected in the full-dataset analysis was influenced by high 
MAF in both the old and young Broad cases. In contrast to the 30 statistically significant SNPs 
under both Model 1 and Model 2a, SNPs in 2 known AD genes (APOE and TOMM40) significant 
only under Model 1 showed similar MAF across all three centers and clear separation between 
case and control MAF (Figure 2.17). 
 
DISCUSSION 
To characterize the impact of batch effect and study design on downstream genomic 
analysis, we conducted association tests on the 9,904 exomes of the ADSP case-control dataset, 
which is composed of cohorts from three sequencing centers. We used four models with 
different sets of covariates. Each model adjusted for PCs and sequencing center. Model 1, the 
base model, and Model 2a, which further adjusted for APOE, identified a shared set of 30 highly 
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significant SNPs after quality control. Most of these SNPs had no previously reported AD 
association based on a review of the literature. In contrast to Models 1 and 2a, the two models 
that accounted for age (Models 2b and 3) found few SNPs statistically significant, indicating that 
the adjustment applied for age (a known confounding variable, as described above) eliminated 
the association between sample class (case or control) and disease. This result echoes a recent 
report that found only one exome-wide significant SNP in the ADSP dataset under age-adjusted 
models (Bis et al. 2018).  
 
The impact of batch on the detected associations 
The fact that multiple sequencing centers and exome capture kits were used to create 
this dataset prompted us to investigate batch effects and their impact on association analysis. 
We repeated the association tests separately on each center’s set of samples and found that 
just 8 SNPs significant under Model 1 and 1 SNP significant under Model 2b were shared across 
all three cohorts; zero were shared between all three cohorts under Models 2a and 3. We also 
investigated cohort-level differences in the 30 highly significant AD-associated SNPs identified in 
the full-dataset analysis. Although not significant in the WashU and Baylor cohorts, these 30 
SNPs displayed highly significant AD association and relatively high MAF in the Broad cohort, 
mirroring the results seen in the full-dataset analysis. This result indicates that the Broad 
samples drove the significance of these SNPs in the full-dataset analysis despite the use of a 
covariate to adjust for sequencing center, perhaps due to the complex relationship between 
center, age and AD association. 
Several distinctions between the cohorts assembled at each center could have 
influenced the paucity of shared AD-associated variants. One such distinction is the exome 
capture kit used by each center. The comparison of the quality-metric ratio distributions 
between the Illumina-captured cohort (Broad) and the Nimblegen-captured cohorts (WashU 
and Baylor) revealed that variants with the greatest disparities in GQ could distinguish the 
genotypes detected by the two capture kits. Therefore, systematic differences in GQ between 
capture kits could contribute to the minimal overlap of significant variants across cohorts. 
However, 26 of the 30 of the highly significant SNPs from the full-dataset analysis without age 
correction did not exhibit large differences in GQ or other metrics between the Broad, WashU 
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and Baylor samples. Moreover, GQ was generally high at these SNPs. These results indicate that 
quality issues alone could not explain the differences between centers manifested in the 
discrepant minor allele frequencies of the 30 SNPs profiled, although GQ may well have 
contributed to the differences between capture kits at a more global level. Instead, a more likely 
explanation for the observed trends of significance and MAF at the 30 SNPs involves 
heterogeneity among the sampled individuals assembled for each cohort. 
 
The impact of age and population stratification on the detected associations 
We speculated that age differences may have contributed to the observed discrepancies 
in significance between sequencing centers because the Broad cohort consisted of a 
disproportionately large number of younger cases. To understand how this disparity might 
influence the ability to detect AD-related variation, we repeated the association tests on four 
age groups within each center’s cohort and examined the significance of the 30 SNPs profiled 
earlier. Under this analysis, their significance fell to negligible levels in all age groups except the 
oldest (85+) in Broad. At 4 of the 30 SNPs, the Broad samples reached exome-wide significance 
in samples aged 85 and older, which implies true AD association of these SNPs in this age group 
in Broad. However, the remaining 26 SNPs were not statistically significant in any age group in 
Broad under this stratified analysis, possibly due to reduced power from smaller sample size 
within each age stratum. The 30 SNPs were more frequent among all age groups in Broad cases 
and controls compared to WashU and Baylor, particularly in younger samples. The parallel 
decline in MAF with age in both Broad cases and Broad controls at all 30 SNPs suggests that the 
SNPs are associated with age in Broad. Although the over-representation of younger Broad 
individuals classified as cases may have impacted the detected AD association, the impact of 
age does not exclude the possibility of true AD association as well.  
The biological reason for higher MAF in Broad samples compared to WashU and Baylor 
samples at these SNPs remains unclear from the available data. One possibility is divergent 
genetic backgrounds among the sub-populations sampled in each center’s cohort, although 
more information is needed to investigate this scenario. Population stratification, which is the 
regular pattern of disparate allele frequencies between sub-populations, reflects ancestral 
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differences in study participants (M. Li et al. 2010). To account for differing genetic backgrounds, 
association models generally include a covariate that adjusts for PCs of the detected genotypes, 
which are often correlated with ancestry (Martin et al. 2018). However, the global ancestral 
differences captured by PCs may not reflect sub-population differences at the individual SNP 
level, which may explain why the PC covariate failed to reduce the significance of the 30 profiled 
SNPs to lower levels.  
 
The possible biological bases for the significance of the top SNPs 
Regardless of the origin of their Broad-specific association with AD and age, several of 
these SNPs lie in genes previously linked to neural diseases: TMED1, PLXNB1, CIC, CEP164 and 
CCNK. TMED1 interacts with APP (Del Prete et al. 2016), whose cleavage into amyloid beta 
generates one of the key components of AD-associated pathological protein aggregation (Penke 
et al. 2017). PLXNB1 influences amyloid beta load (Mostafavi et al. 2018), and CIC is a 
transcriptional repressor whose inactivation promotes gliomagenesis, the formation of glial 
tumors in the brain (Yang et al. 2017). CEP164 binds to TTBK2, a kinase that phosphorylates tau 
(Liao et al. 2015) and that contributes to neurodegeneration in frontotemporal dementia (Taylor 
et al. 2018).  
Interestingly, we found two statistically significant synonymous SNPs and one 
suggestively significant synonymous SNP in CCNK, but no significant non-synonymous SNPs in 
this gene. Mutations in CCNK, which encodes the transcriptional regulator Cyclin K, have been 
previously associated with neurodevelopmental abnormalities (Fan et al. 2018). Synonymous 
SNPs are typically excluded from GWAS analysis because they do not change amino acid 
composition; however, differences between synonymous codons can impact mRNA secondary 
structure (Gu et al. 2010), the rate of translation (Ikemura 1985; Spencer et al. 2012) and co-
translational protein folding (Spencer et al. 2012) and have been reported in connection to 
disease (reviewed in Hunt et al. 2014). Given the role of this class of variants in protein 
dynamics and its customary exclusion from GWAS analysis, the potential contribution of 
synonymous SNPs to disorders characterized by pathological protein aggregation, such as AD, 
has been overlooked and warrants further study.  
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Although not conclusive, these intriguing connections between neural disease and the 
SNPs identified here indicate that there may be a biological basis of the observed findings in the 
Broad cohort, but it is not possible from these data to determine whether the SNPs are 
associated with AD or with longevity due to other factors. Further study is necessary of both the 
population genetics of these SNPs in Broad and their impact on aging and AD. 
 
CONCLUSIONS 
To illustrate the impact of batch effect and confounding variables on downstream 
analysis, we conducted stratified association analysis on AD exome data using models with 
multiple combinations of covariates. We profiled a set of SNPs with highly significant, novel 
associations with AD that were impacted by heterogeneity in sub-cohort composition. We 
identified genotype quality, age and population stratification as likely contributing factors to 
vastly different minor allele frequencies across sequencing center cohorts. Collectively, our 
findings suggest that exome sequencing and other studies should follow consistent sample 
collection and sequencing protocols, use the same target capture kit, and minimize variation 
unrelated to disease phenotype between sample classes in order to locate truly significant 
disease-associated loci for challenging diseases. 
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Figure 2.2. Manhattan plots of AD association under four models. Log-transformed p-values 
under each model are shown. All models included the covariates of sequencing center and PCs. 
In addition, Model 2a included APOE and sex, Model 2b included age and sex, and Model 3 
included APOE, age and sex. The red horizontal line denotes exome-wide significance and the 





























Figure 2.3. Number of statistically significant (p < 3.0 x 10-7)  AD-associated variants under 




























Table 2.3. SNPs reaching exome-wide significance (p < 3.0 x 10-7) under Models 1 and 2a after 







































Figure 2.4. Log-transformed p-values for AD association under each model stratified by 
sequencing facility cohort. SNPs shown reached exome-wide significance under Models 1 and 







































Figure 2.5. Minor allele frequencies in the cases and controls stratified by sequencing facility. 



















Figure 2.6. Number of nominally AD-associated (p < 0.005) QCed variants and their overlap 































Figure 2.7. Global distributions of quality-metric ratios between QCed samples from each 
exome capture kit. Each data point represents the log of the ratio of the Illumina-captured 




















Figure 2.8. Principal component loadings at the 10% tails of quality-metric ratio distributions. 
Principal components were computed using as input the 9,904 samples’ genotypes at the SNPs 
lying within the top 5% and bottom 5% of the distributions for GQ and DP, and the bottom 10% 






















Figure 2.9. Principal component loadings at the middle 90% of quality-metric ratio distributions. 
Principal components were computed using as input the 9,904 samples’ genotypes at the SNPs 










































Figure 2.10. GQ distributions from the cases and controls stratified by sequencing center. SNPs 







































Figure 2.11. Read depth distributions from the cases and controls stratified by sequencing 






































Figure 2.12. Minor allele concentration distributions from the cases and controls stratified by 























Figure 2.13. Age distributions for cases and controls from each cohort. The bold line inside each 

















































































Figure 2.15. Log-transformed p-values for AD association stratified by sequencing facility and 
age group. The top dotted horizontal line denotes exome-wide significance in Broad and the 
bottom dotted horizontal line denotes suggestive significance in Broad. SNPs shown reached 








































Figure 2.16. Minor allele frequencies in cases and controls stratified by sequencing facility and 
age group. SNPs shown reached exome-wide significance under Models 1 and 2a in the full-
dataset analysis. Allele frequencies of controls in the youngest group are omitted because each 
























Figure 2.17. Minor allele frequencies in cases and controls stratified by sequencing facility and 
age group. SNPs shown were shared among all three sequencing facilities and reached genome-
wide significance under Model 1 in the full-dataset analysis. Allele frequencies of controls in the 






















Parts of this chapter were published as Wickland et al, 2017: A comparison of genotyping-by-sequencing analysis 
methods on low-coverage crop datasets shows advantages of a new workflow, GB-eaSy. BMC Bioinformatics 18(1): 
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CHAPTER 3: A COMPARISON OF GENOTYPING-BY-SEQUENCING (GBS) ANALYSIS METHODS ON 
LOW-COVERAGE CROP DATA SHOWS ADVANTAGES OF A NEW WORKFLOW, GB-EASY 
 
BACKGROUND 
Genotyping-by-sequencing (GBS), a simplified reduced-representation sequencing 
approach (Elshire et al. 2011), has gained popularity in crop research and plant breeding for 
high throughput, low-cost genotyping. It has been applied to projects ranging from genomic 
selection to gene mapping to genome-wide association studies in numerous crop species 
(Furuta et al. 2017; Liu et al. 2014; Poland et al. 2012; Sonah et al. 2015; Wu et al. 2016). GBS 
relies on restriction enzymes to generate a reduced representation of the genome for 
sequencing. Compared to other approaches such as RAD-seq, the GBS library preparation 
protocol involves fewer steps, requires less DNA, and lacks a size selection step (Elshire et al. 
2011). In GBS, DNA samples are digested and ligated to barcoded adapters in single wells, 
pooled, and then enriched by PCR. In contrast to the relatively simple and straightforward 
library preparation, GBS data analysis is complicated by the nature of the random location, 
reduced-representation approach.  
Bioinformatics software packages and workflows have been developed to provide the 
architecture for analysis of reduced-representation sequencing data (Catchen et al. 2013; 
Sonah et al. 2013; Torkamaneh et al. 2017). Several of these platforms utilize the same tools 
and algorithms commonly applied to whole-genome sequence data, while others utilize 
algorithms developed specifically for GBS and RAD sequencing. Although designed to facilitate 
and simplify data processing, these GBS pipelines nevertheless can be difficult for non-specialist 
researchers such as plant breeders to install or implement. Issues include high levels of 
complexity, requirements for additional libraries or uncommon packages, or additional 
processing steps outside of the pipelines. A different approach, TASSEL / TASSEL-GBS (Bradbury 
et al. 2007; Glaubitz et al. 2014), provides an all-in-one desktop software package that is easy to 
install and use, and performs both GBS data processing and genetic analysis using the resources 
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of a stand-alone PC. However, while this software is widely adopted in cereal genetics, it was 
optimized for use in maize, and uses heuristics such as the reduction of reads to tags before 
alignment to enable reasonable run times on PC hardware. These heuristics are less clearly 
advantageous in recently polyploid species; for this reason, others (e.g. Torkamaneh et al. 
2017) have developed different approaches for crops such as soybean. Finally, the all-in-one 
software package approach means that users cannot themselves easily modify TASSEL-GBS to 
accommodate new sequencing technology or other software packages. 
More recently, known segregating sites from pan-genome data have been shown to 
substantially improve accuracy and yield from reduced-representation sequencing (Lu et al. 
2015); however, for other crops such as soybean and many others important for food 
production, population-level diversity is not yet sufficiently well characterized at the whole-
genome level, and better tools to identify SNPs ab initio are still needed. In addition, recently 
polyploid genomes such as soybean (Schmutz et al. 2010) present a complication to the 
performance of alignment and variant calling for all forms of reduced-representation 
sequencing. This may influence the performance of different approaches relative to more 
straightforward diploid genomes. 
Here we present GB-eaSy, a GBS bioinformatics pipeline that efficiently incorporates 
widely used genomics tools, parallelization and automation to increase the accuracy, efficiency 
and accessibility of GBS analysis. GB-eaSy has been specifically developed to be straightforward 
to install and use on typical UNIX / HPC hardware, to contain readily updateable public software 
where possible, and to match or exceed the performance of current GBS SNP-calling methods 
used on soybean or other complex, repetitive and recently polyploid genomes. It can process 
reduced-representation data from any organism with a reference genome. We compared the 
performance of GB-eaSy to four other GBS bioinformatics data analysis platforms using low-
coverage Illumina sequence data from three soybean populations. GB-eaSy rapidly and 
accurately identified the greatest number of SNPs across all three populations, with SNP calls in 
close agreement with whole-genome sequencing of selected lines. In addition, the 
unexpectedly low convergence between the five analysis methods but generally high accuracy 
indicated that the workflows arrived at largely complementary sets of valid variant calls. 
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MATERIALS AND METHODS 
Samples 
GBS libraries were constructed from three soybean populations (Table 3.1). Population 
1 consisted of 378 F2 lines resulting from a cross between the accession Prize and an NMU-
mutagenized individual from the reference genotype Williams 82. Population 2 contained 391 
F2 individuals from a cross between two breeding lines. Finally, Population 3 consisted of 81 
unrelated accessions (with 2-4 replications) that form an association panel. DNA was extracted 
using the CTAB method (Richards et al. 2001) except for the Prize x NMU-mutagenized Williams 
82 population (Population 1), which used the E-Z 96 Plant DNA kit (Omega Bio-Tek, Norcross, 
GA). All libraries were sequenced at low coverage typical of plant breeding experiments, with 
coverage varying from 1.87x to 4.47x. 
 
GBS library preparation  
GBS libraries were prepared according to the two-enzyme protocol described in Poland 
et al. 2012 with minor modifications (kindly provided by Dr. P. Brown, UC Davis). Two-enzyme 
pairs (HindIII-MseI and HindIII-BfaI) were used to achieve a balanced representation of HindIII 
cut sites. In brief, restriction and ligation were carried out simultaneously, followed by PCR 
amplification. First, 5 μl of DNA (25-50 ng/μl, 125-250ng total) from each sample was pipetted 
into its own well on a 384-well plate that contained restriction-ligation master mix. The master 
mix in each well consisted of 2.5μl 10X NEB CutSmart buffer (final concentration 1X), 2.5μl 10 
mM dATP (final concentration 1 mM), 0.1μl (2U) HindIII, 0.2μl MseI or BfaI, 0.1μl concentrated 
T4 DNA ligase (40U), 0.5μl each of 10uM adapters, and 14.1 μl molecular biology-grade water. 
The barcoded “rare adapters” were designed to anneal to the cut HindIII site, while the non-
barcoded “common adapters” annealed to the cut MseI or BfaI site. 
The 384-well plates underwent digestion and ligation in the thermocycler at 37°C for 1 
min, 25°C for 1 min, repeated 100 times. Next, 8 μl from each well was pooled into a 1.5mL 
microfuge tube, cleaned using Agencourt AMPure XP beads (Beckman Coulter Life Sciences, 
Indianapolis, Indiana, USA), dried, and suspended for PCR amplification in a solution of Phusion 
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Master Mix (NEB, Ipswich, MA). PCR settings for amplification were 98°C for 30s, 15 cycles 
(98°C for 10s, 68°C for 30s, 72°C for 30s), 72°C for 5m, followed by 4°C until sample recovery. 
Next, AMPure cleanup was repeated, and the resulting library was evaluated on a Bioanalyzer 
2100 (Agilent, Santa Clara, CA) using a DNA7500 chip to assess amplification success, fragment 
size, and DNA concentration. Finally, each library was diluted to 10 nM DNA in LIB buffer 
(10mM Tris-HCL (EB) w/ 0.05% Tween-20) and run on either an Illumina HiSeq2500 or 
HiSeq4000 using the HiSeq SBS sequencing kit version 4 at the Roy J. Carver Biotechnology 
Center at the University of Illinois at Urbana-Champaign. 
 
GBS data analysis platforms 
TASSEL-GBS 
TASSEL-GBS was developed to assign SNP genotypes from GBS data in a time- 
and storage-efficient manner (Glaubitz et al. 2014) (Table 3.2). Unlike SNP calling for 
whole-genome data, which involves first aligning all reads to the reference genome and 
then calling SNPs, TASSEL-GBS dramatically reduces computational demands by 
consolidating reads into a master “tag list” containing the unique sequences. This tag list 
is then aligned to a reference genome. For species lacking a reference genome, the 
consensus allele at each position is considered the reference allele. Variant 
identification in the TASSEL5GBSv2 pipeline (https://bitbucket.org/tasseladmin/tassel-5-
source/wiki/Tassel5GBSv2Pipeline) consists of two main steps: SNP discovery and 
production SNP calling. In SNP discovery, TASSEL-GBS determines SNPs and SNP 
coverage within each tag for each sample and outputs the results to a database. In 
production SNP calling, SNP genotypes in each sample are output. Each step is 
performed internally with TASSEL-GBS plugins, except alignment, which is carried out 
externally using software such as BWA-MEM (H. Li 2013). Prior to running TASSEL, we 
removed adapter sequence from the reads using cutadapt (Martin 2011) after finding 
that adapter contamination severely impaired the accuracy of TASSEL-GBS SNP calls 




Stacks is a software package developed for RAD sequencing that identifies SNPs 
and calculates population statistics from any restriction enzyme-based, reduced-
representation sequence data (Catchen et al. 2013) (Table 3.2). After demultiplexing 
and cleaning the sequenced reads, Stacks assembles loci from each sample (with or 
without a reference genome) and groups together loci across samples to construct a 
catalog. Comparison between the catalog and loci from each sample allows inference of 
SNPs and genotypes. Optional additional steps include creation of genetic maps and 
calculation of population statistics. Like TASSEL-GBS, each step except alignment (here 
performed by BWA-MEM) uses the software’s internal algorithms.  
 
IGST 
IGST (IBIS Genotyping by Sequencing Tools) processes GBS data by implementing 
several popular genomic software tools connected by Perl and Python scripts (Sonah et 
al. 2013) (Table 3.2). After setting up a predefined directory structure and naming input 
files according to a specific convention, the user issues a single command that runs the 
entire pipeline. IGST demultiplexes and cleans barcoded reads using Sabre 
(https://github.com/najoshi/sabre), aligns demultiplexed reads to the reference 
genome using BWA-ALN (H. Li and Durbin 2009), converts the aligned sequences to BAM 
format using SAMtools (H. Li 2011), and identifies SNPs using SAMtools and BCFtools (H. 
Li 2011). The resulting SNP calls are filtered by VCFtools (Danecek et al. 2011).  
 
Fast-GBS 
Fast-GBS follows a strategy similar to IGST but employs a different alignment 
algorithm, a different variant caller, and a bash script that runs each software program 
(Torkamaneh et al. 2017) (Table 3.2). As with IGST, the user must set up a predefined 
directory structure and name files according to a specific convention before inputting a 
single command to run the workflow. This pipeline demultiplexes reads using Sabre, 
trims and cleans reads using Cutadapt, aligns reads to the reference genome using BWA-
MEM, and calls variants using Platypus (Rimmer et al. 2014). As a haplotype-based 
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variant caller, Platypus identifies single-allele SNPs as well as compound SNPs consisting 
of short strings of adjacent alleles. To facilitate comparisons with the other pipelines, we 
used the VariantsToAllelicPrimitives script within the Genome Analysis Toolkit (Van der 
Auwera et al. 2013) to deconvolute the multi-allelic SNPs into individual allelic 
primitives, as recommended by Baes et al. 2014. 
 
GB-eaSy 
The GB-eaSy pipeline developed for this project consists of a Bash shell script 
that executes several bioinformatics software programs in a parallel UNIX / Linux 
environment. This workflow requires a reference genome and is compatible with both 
single- and paired-end Illumina reads. Its name derives from its straightforward, 
transparent implementation of GBS variant calling; GB-eaSy is appropriate for users 
without extensive command-line expertise as well as for experienced bioinformaticians 
who may choose to modify any step of the script. GB-eaSy implements the same well-
tested and regularly updated tools commonly adopted in whole-genome sequencing. In 
contrast to some GBS pipelines, GB-eaSy does not require the user to follow strict 
instructions regarding directory structure or file names; instead, the Bash script 
performs these steps automatically. The GB-eaSy shell script, a walkthrough of each 
command, and a tutorial using sample data are hosted at 
https://github.com/dpwickland/GB-eaSy. 
Before starting the pipeline, the user modifies a parameters file with settings 
customized for their GBS project (e.g. path to raw sequencer output file, path to 
barcodes file, number of CPU cores to use). The user then issues a single command to 
execute the pipeline. The first step of GB-eaSy uses the software GBSX (Herten et al. 
2015) to demultiplex reads and trim adapter sequences based on a user-created 
barcodes file containing the short barcode sequences that uniquely identify each 
sample; for our study, we modified the GBSX script (GBSX.jar) to include the HindIII cut 
site, which was not supported initially. Next, demultiplexed reads are aligned to the 
reference genome using BWA-MEM; GB-eaSy hastens this alignment step by processing 
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read files in parallel using GNU Parallel (Tange 2011). After alignment, BCFtools is used 
to create a pileup of read bases from which it calls SNPs. This SNP-calling step uses GNU 
Parallel to process each entry in the reference genome file (e.g. each chromosome, each 
scaffold) on its own CPU core, greatly increasing the efficiency of SNP identification. 
Finally, the output VCF file is filtered by VCFtools according to a user-specified minimum 
read depth (Table 3.2).  
 
Whole-genome sequencing 
To validate the output from the GBS pipelines, Illumina whole-genome sequence (WGS) 
data was obtained (experimentally in the case of Prize for Population 1 and the case of LG12 for 
Population 2, or from the data obtained by Song et al. 2017 for four lines of the soybean NAM 
association panel for Population 3) for comparison of GBS and WGS SNP calls (Table 3.3). As 
with the GBS pipelines, WGS reads were aligned to the reference genome using the software 
BWA-MEM. However, variant calling on the WGS datasets was carried out with GATK 
HaplotypeCaller (Van der Auwera et al. 2013), a tool not used by any of the GBS pipelines, to 
provide independent assessment of GBS SNP call accuracy. 
 
Pipeline comparisons 
The five GBS pipelines and the WGS pipeline described above were run with the 
following parameters to make the analysis as equivalent as possible between workflows: 
minimum read length of 80 bases after adapter and barcode trimming, minimum base quality 
of 20 and minimum mapping quality of 20 for variant calling (corresponding to a 1 in 100 
chance of an incorrect base call or mapping call, respectively), and identification of SNPs only 
(no indels). Other parameters were set at default values. The software package VCFtools was 
then used to remove SNP calls supported by less than 2 reads (i.e. minimum depth of 2 reads) 
to increase the reliability of distinguishing homozygous from heterozygous genotypes (note 
that our lowest coverage dataset has an average depth per sequenced base of 1.87x). Recent 
versions* of component software packages and commands were used for each pipeline, with 
the following exceptions: for IGST, commands were run using SAMtools version 0.1.18 and 
Picard version 1.119 because the IGST workflow was incompatible with later versions. Finally, 
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11 CPU cores were used at any steps that offered an option for parallelization. In-house scripts, 
BCFtools and VCFtools were used to compute and compare the number of chromosomal SNPs 
identified by the pipelines and to calculate missing data values. All programs were run on a 
Linux server with two Intel® Xeon® X5650 processor chips, each with six CPU cores, and 48 GB 
RAM. 






GNU parallel 20170122 
Cutadapt 1.12 





GBS SNP calls and their agreement with WGS SNP calls 
We compared the SNP calls within and between pipelines on three different 
populations. Populations 1 and 2 were each 384-well plates used to sequence populations of F2 
individuals chosen to mimic mapping populations or breeding studies, while Population 3 was a 
set of 81 diverse lines, again replicated across a 384 well plate, that can be used as a GWAS 
diversity panel (Song et al. 2017). Population 1 was derived from a cross between Prize (a US-
adapted cultivar) and Williams 82 (the target of the reference genome project (Schmutz et al. 
2010), while Population 2 was derived from a cross between two breeding lines that should be 
equally distant from the reference genome. After preparing GBS libraries and obtaining low-
coverage Illumina sequence data (ranging from 1.87 to 4.47x depth per sequenced base), we 
called SNPs using the five pipelines and computed the total number of SNPs identified and the 
number of SNPs shared between pipelines. In addition, we compared the GBS SNP calls to WGS 
SNP calls of selected lines to calculate the SNP concordance and allelic concordance between 
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GBS and WGS. The analysis excluded indels to simplify comparisons among the methods 
because some methods call only SNPs and because SNPs are the markers of choice in most 
breeding projects. All SNPs were called relative to the Williams 82 soybean reference genome. 
In terms of SNP yield, the relative ranking of each pipeline remained similar across all 
three populations: GB-eaSy called the most SNPs, followed in order by Fast-GBS, IGST and 
Stacks (rank depending on population), and TASSEL-GBS (Figure 3.1). In Population 1, the 
number of SNPs identified ranged from 35,328 (TASSEL-GBS) to 88,298 (GB-eaSy). Population 2 
had the greatest number of SNP calls, ranging from 88,423 (TASSEL-GBS) to 249,472 (GB-eaSy); 
the comparatively large SNP yield of Population 2 likely resulted from the HiSeq4000 outputting 
150,000 more reads than the HiSeq2500 used with Populations 1 and 3 (Table 3.1). In 
Population 3, the number of SNPs called ranged from 78,848 (TASSEL-GBS) to 163,571 (GB-
eaSy). Within each population, a small portion of SNPs was called by all five workflows, with the 
proportion of convergent SNPs being roughly consistent (Figure 3.2A). A similar trend appears 
in the data for individual soybean lines (Figure 3.2B). 
Because the SNP concordance between GBS analysis platforms was unexpectedly low 
(Figure 3.2), whole-genome data of six lines was obtained for comparison of GBS and WGS SNP 
calls. To avoid biasing these comparisons in favor of a particular GBS platform, GATK 
HaplotypeCaller (a tool not used by any of the GBS workflows) was used to call SNPs in the WGS 
datasets. The GBS data for these individual lines follows the population-level pattern of GB-
eaSy finding the most GBS SNPs, closely followed by Fast-GBS (Figure 3.3A). SNP concordance 
was calculated as the percentage of GBS SNP sites (e.g. chromosome 1, position 8144) that 
were also identified by WGS (Figure 3.3B). Depending on the line under study, either Stacks, 
TASSEL-GBS or IGST exhibited the highest SNP concordance with WGS. Across all pipelines, SNP 
concordance was relatively lower in the lines Magellan, Maverick, Prohio and Skylla due to the 
low coverage of their WGS data (ranging from 2.02x to 5.37x) and therefore fewer sites 
sampled (Figure 3.3B).  
We also assessed the allelic agreement (e.g. chromosome 1, position 8144, nucleotide 
C) between GBS SNP calls and WGS SNP calls for the set of concordant SNPs identified above 
(Figure 3.3C). In every line examined, GB-eaSy, TASSEL-GBS and IGST all achieved high allelic 
agreement (above 99%) with WGS, Fast-GBS reached allelic agreement between 97.19% and 
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99.54%, and Stacks reached allelic agreement between 95.55% and 98.45%. While GB-eaSy, 
TASSEL-GBS and IGST attained similarly high WGS-agreement rates, GB-eaSy identified the 
greatest number of SNPs in allelic agreement with WGS in each line (Figure 3.3D).  
 
Missing data 
GBS, unlike RAD-seq used for biological diversity analysis, is tuned to identify as many 
SNPs as possible, with missing data accounted for in later analysis by imputation of haplotypes 
using reference genome data. However, any GBS data analysis must consider the large 
proportion of missing/unsampled data, which can often be a limiting factor in downstream 
applications of the genotype data. The more sensitive a method is to polymorphisms with lower 
coverage, the more missing data in percentage terms is likely to be observed when comparing 
samples; therefore, the key parameter is the outright number of SNPs that are present in a 
sufficient proportion of lines for the analysis to be used. Within the three populations, the 
average percentage of sampled SNPs not present in any given line was fairly consistent: 83.4% 
(GB-eaSy) to 89.7% (Stacks) in Population 1, 59.4% (TASSEL-GBS) to 71.5% (GB-eaSy) in 
Population 2, and 62.4% (TASSEL-GBS) to 69.6% (GB-eaSy) in Population 3 (Table 3.4). In 
Population 1, GB-eaSy found the most SNPs present in at least 25% and 50% of sampled lines, 
while TASSEL-GBS found more SNPs present in at least 75% and 90% of sampled lines (Table 
3.4). In Population 2, Stacks identified the most SNPs present in at least 25% of lines, GB-eaSy 
identified the most present in at least 50% and 75% of lines, and TASSEL-GBS identified the 
most SNPs in at least 90% of lines. Finally, in Population 3, Fast-GBS found the greatest number 
of SNPs present in at least 25% of lines, while GB-eaSy found the greatest number of SNPs 
present in at least 50%, 75% and 90% of lines. In this case, the variation in performance across 
the three populations was substantial, but GB-eaSy showed the best or among the best 
performance for each population. Notably, since each pipeline produces a different subset of 
valid SNPs (Figure 3.2B), the optimal strategy for minimizing missing data is likely the 




Run time and disk space 
The pipelines differed widely in their time to completion. TASSEL-GBS (including the 
initial Cutadapt step) finished most rapidly for each population (Table 3.5), as expected from its 
extensive use of tag heuristics to speed alignment. Fast-GBS and GB-eaSy alternately ranked as 
second and third fastest, depending on the population and the total number of reads. Stacks 
and IGST used the most wall-clock time per sample, with IGST taking at least three times as long 
as TASSEL-GBS in every population. 
The disk space required paralleled the run time in most pipelines (Table 3.6). For each 
population, TASSEL-GBS required the least amount of storage. GB-eaSy and Stacks used 
approximately twice the disk space required by TASSEL-GBS. Despite their parameters being set 
to delete intermediate files where applicable, IGST and Fast-GBS used substantially more disk 
space than the other methods. 
 
DISCUSSION 
Despite the availability of multiple tools for GBS data processing, a need exists for a GBS 
pipeline that is easy to install, interfaces with standard tools, is optimized for high density SNP 
calling in polyploid crop genomes, and quickly and reliably identifies a large number of accurate 
SNPs while minimizing its storage footprint. We developed GB-eaSy, a GBS bioinformatics 
pipeline suitable for both command line novices and experienced bioinformaticians, and aim it 
primarily at the soybean community, where use of such processing software is increasing. 
However, GB-eaSy should be applicable to any non-model plant species with a reference 
genome, particularly to polyploids with repetitive genomes such a soybean. The 1.1-gigabase, 
recently paleopolyploid soybean genome contains multiple copies of 75% of its genes (Schmutz 
et al. 2010), which presents challenges to accurate processing of genomic data. Therefore, 
soybean qualifies as a suitable test subject to assess the accuracy of GB-eaSy’s SNP calls. 
Comparison of GB-eaSy to other GBS data workflows indicated that GB-eaSy rapidly and 
accurately identified the most SNPs in all three soybean populations examined, without 




Different SNP calling strategies 
A key difference among GBS pipelines that may explain their discrepant results is the 
software used for variant calling, and its approach to determining the consensus genotype in a 
group of reads and whether that consensus varies from the reference. Both IGST and GB-eaSy 
use BCFtools/SAMtools as the variant caller, which relies on a Bayesian strategy to select as the 
consensus genotype at a given locus the base with the highest Phred score that maximizes the 
posterior probability (O’Rawe et al. 2013). If the consensus genotype at the locus differs from 
the reference, a SNP is called. Previous work has validated the accuracy of the BWA and 
SAMtools/BCFtools combination used in IGST and GB-eaSy. For instance, Hwang et al. 2016 
evaluated thirteen variant calling pipelines consisting of combinations of three read aligners 
(BWA-MEM, Bowtie2, Novoalign) and four variant callers (GATK HaplotypeCaller, SAMtools 
mpileup, Freebayes, Ion Proton Variant Caller) against a dataset of highly confident “gold 
standard” human variants published by the 1000 Genomes Project. In that study, the 
combination of BWA-MEM with SAMtools achieved the greatest accuracy in SNP identification. 
The two pipelines using these tools in our study (IGST and GB-eaSy) attained the greatest allelic 
concordance with WGS in the six lines studied. 
Each of the other three pipelines investigated here uses a different variant caller. 
TASSEL-GBS, which calls SNPs using its own binomial likelihood ratio method (Glaubitz et al. 
2014), also agreed well with WGS SNP calls. However, because it found fewer SNPs overall, 
TASSEL-GBS’ number of validated SNPs was lower than that of GB-eaSy and IGST. Stacks uses a 
multinomial-based likelihood model for SNP calling, which produced an allelic agreement above 
95% but the fewest validated SNPs in each line due in part to its finding fewer SNPs overall. 
Stacks’ variant caller consults the reference genome only for read placement, not for nucleotide 
comparisons, as it is optimized for high-coverage analysis of biological diversity RAD sequencing 
experiments in which reference genomes are often not available (Catchen et al. 2013). For the 
low-coverage data typical of plant breeding studies, it is likely a disadvantage that Stacks does 
not utilize the Bayesian priors available from high-quality reference genomes. However, for 
organisms lacking a reference genome, the Stacks approach is likely optimal. Finally, Fast-GBS’ 
variant caller, Platypus, uses a haplotype-based strategy to identify variants. A previous analysis 
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(Torkamaneh et al. 2016) found that comparison of Fast-GBS SNP calls with WGS data in 
soybean yielded an accuracy of 98.7%, a result consistent with those presented here. Platypus’ 
superiority in indel identification but comparatively lower performance in SNP calling has been 
reported (Tian et al. 2016), which may explain its slightly lower agreement with WGS compared 
to the tools used in TASSEL-GBS, IGST and GB-eaSy.  
Across all six soybean lines examined, GB-eaSy, TASSEL-GBS and IGST identified SNPs 
with the greatest accuracy (over 99%), based on comparison to WGS SNPs called by GATK 
HaplotypeCaller. The accuracy of Fast-GBS and Stacks was lower but still reasonably high (never 
below 97%). This high accuracy among all five workflows, coupled with the low SNP 
convergence between them, indicates that they arrived at largely complementary sets of valid 
SNP calls. For instance, GB-eaSy, TASSEL-GBS and IGST converged on just 2501 (12.85%) of their 
total 19465 unique SNPs found in Prize. Similarly, these three pipelines converged on just 6781 
(17.02%) of their 39853 unique SNPs found in Skylla. These results echo a previous report on 
barley GBS data in which approximately half of SNPs called by TASSEL-GBS and 
BCFtools/SAMtools were unique to each pipeline (Mascher et al. 2013).  
 
Storage, run time and ease of use 
TASSEL-GBS, the workflow with the smallest storage requirements, used approximately 
half of the hard disk space required by Stacks and GB-eaSy. While it used the least disk space, 
TASSEL-GBS identified the fewest SNPs. Both IGST and Fast-GBS found more SNPs than TASSEL-
GBS but required the largest amount of disk space due to their generation of many 
uncompressed intermediate files, even with parameters set to delete intermediate files where 
possible. This characteristic could hinder their adoption by users with limited computer storage 
capacity. Across pipelines, these patterns also emerged in run time differences, which may be 
determined to a large extent by read-write rather than CPU operations. IGST and Stacks 
required considerably more time to run than TASSEL-GBS, Fast-GBS and GB-eaSy. For instance, 
IGST needed over 18 h to process data from Population 2, while TASSEL-GBS finished in less 
than 5 h. Long completion times limit the throughput of data processing, making the slower 
pipelines less suitable for time-sensitive projects. GB-eaSy’s run times were intermediate, 
ranking ahead of IGST, Stacks and occasionally Fast-GBS but behind TASSEL-GBS. 
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Given the complexities of GBS analysis, a critical element of any bioinformatics pipeline 
is ease of use. The five analysis platforms in this study rely on two command input strategies. In 
TASSEL-GBS and Stacks, the user inputs individual commands that each run a different step of 
the pipeline. In contrast, IGST, Fast-GBS and GB-eaSy automate this process by requiring just 
one command from the user to execute all steps; however, IGST and Fast-GBS also depend on 
adherence to a rigid convention for file naming and directory structure to ensure successful 
completion. GB-eaSy does not require the user to follow strict instructions for setting up 
directory structure or naming files. Instead, it uses a parameters file to customize the analysis 
for each project based on user input. 
Another consideration in ease of use is the ability of a method to carry out all the steps 
necessary to produce accurate SNP calls. For our data, TASSEL-GBS and Fast-GBS required extra 
steps not built into their pipelines to improve the accuracy of their SNP calls. Fast-GBS initially 
appeared to identify significantly fewer SNPs than the other methods and showed lower 
agreement with WGS. However, after decomposition of compound SNPs into allelic primitives 
using the VariantsToAllelicPrimitives script in GATK, the apparent performance of Fast-GBS 
improved considerably; these optimized results were used in the comparisons. Prior to running 
TASSEL, we removed adapter sequence from the reads using Cutadapt, adding an additional 
step to the workflow, after finding that adapter contamination significantly impaired the 
accuracy of TASSEL-GBS SNP calls. Again, the optimized results after the trimming step were 
used in the comparisons. In GB-eaSy, these additional steps either are not required or are built 
into the pipeline itself.  
 
CONCLUSIONS 
Here we introduced the GB-eaSy pipeline and compared its performance to four other 
GBS workflows and to whole-genome sequencing on low-coverage data from soybean. 
Differences were apparent between the performance of these methods depending on the aims 
of the developers. TASSEL-GBS was designed for plant breeding applications and to run on 
individual PCs, and is thus optimized for maximum computational efficiency. The compromises 
inherent in the tag strategy limit the number of SNPs that TASSEL-GBS can identify using 
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datasets such as those utilized here. Stacks is a method developed primarily for high-depth RAD 
sequencing on organisms without reference genomes. It is likely to be an excellent choice for 
breeders in orphan crops, as well as for biological diversity applications, but the reference-
genome independence of the variant calling algorithm and the low-coverage data used here 
render the current version less accurate than methods incorporating reference sequences for 
low-depth GBS in soybean. Fast-GBS and IGST are, like GB-easy, methods designed for plant 
breeding applications on complex crops with high-quality reference genomes. The overall 
performance of these methods in terms of SNP number and accuracy is similar. GB-easy has an 
advantage over the other methods in terms of resources needed (particularly disk space), ease 
of implementation, and number of accurate SNPs identified. Although our results demonstrate 
relatively low SNP concordance between GBS pipelines, comparison of each GBS pipeline to 
WGS data indicates that the SNP calls from each are highly accurate, particularly those 
generated by GB-eaSy, TASSEL-GBS and IGST. These findings suggest that a comprehensive 
approach integrating the results from multiple GBS analysis methods may be the optimal 
strategy to obtain the largest, most highly accurate SNP yield possible from low-coverage 
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Table 3.2. Major steps of the 5 GBS workflows analyzed. Each workflow uses a different series 
of tools to carry out read demultiplexing, adapter trimming, alignment to the reference 

















Table 3.3. WGS library data for six lines. Prize and LG12 were also included in GBS Populations 1 
and 2, respectively. Magellan, Maverick, Prohio and Skylla were included in GBS Population 3. 






























Figure 3.1. Number of SNPs identified by each pipeline in 3 populations. SNPs with a minimum 






















Figure 3.2A. SNP overlap among 5 GBS pipelines. SNPs with a minimum read depth of 2 reads 








Figure 3.2B. SNP overlap among 5 GBS pipelines for 6 lines from 3 populations. Prize is from 
GBS Population 1, LG12 is from GBS Population 2, and the four remaining lines are from GBS 
Population 3. SNPs with a minimum depth of 2 reads are shown. All SNPs were called relative to 







Figure 3.3. Comparisons between GBS SNPs and WGS SNPs for 6 individual soybean lines. Prize 
is from GBS Population 1, LG12 is from GBS Population 2, and the four remaining lines are from 
GBS Population 3. Panel A shows the total number of SNPs identified in each line by 5 GBS 
pipelines. Panel B shows the percent of GBS SNP sites from panel A in agreement with WGS for 
each line. Panel C and D show the percent and number (respectively) of GBS SNP alleles from 
panel A in agreement with WGS. SNPs with a minimum read depth of 2 reads are shown. Below 
each soybean line is shown its average depth of sequenced GBS bases followed by its WGS 





Table 3.4. Missing data fraction generated by each GBS pipeline. The average percent of 
missing data per line is shown, as well as the number of SNPs detected at various proportions 
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